Trial Profile
An Open-label Study to Evaluate the Pharmacokinetics of YM178 After Single Oral Administration of 14C-labeled YM178 in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder; Urination disorders
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 23 Apr 2015 New trial record